FDA Agrees To Evaluate Organs-on-Chips For Cosmetics, Food, Supplements Testing

By Beth Wang / April 12, 2017 at 5:35 PM
FDA has entered into a multi-year collaborative agreement with biotechnology company Emulate that will allow the agency to evaluate the potential uses of the company's Organs-on-Chips technology to monitor the simulated human organs' reactions to ingredients in food, cosmetic and supplement products. While the product is still in testing stages, an FDA spokesperson told Inside Health Policy they hope the product will one day be used for regulatory decision-making -- though the spokesperson declined to say whether FDA would...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.